Sling Therapeutics

Biopharma company focused on late-stage development of an oral small molecule for thyroid eye disease (TED).

[Sling Therapeutics @SlingTX]

Knowing the signs and symptoms of thyroid eye disease (#TED) is key to managing the condition effectively. Learn more via @BrighamWomens at https://t.co/XIXWqKIpNK #WomensEyeHealthMonth

[Sling Therapeutics @SlingTX]

This week our team will sponsor and attend the Innovate Thyroid Eye Disease (TED) 2024 Multidisciplinary Symposium to meet with fellow experts in #endocrinology and #ophthalmology and discuss the latest innovations in #TED. For details: https://t.co/1FDYsVcp5A #InnovateTED

[Sling Therapeutics @SlingTX]

Thyroid eye disease (TED) can affect a person’s life in many challenging ways. That’s why we are working to develop a potential new treatment option for #TED. Learn more: https://t.co/4ARw0ACsLt

[Sling Therapeutics @SlingTX]

#DYK that two out of every three people living with blindness or vision problems are women? For #healthyvision tips, visit the @NIH at https://t.co/7YovM6g65Z #WomensEyeHealthMonth

[Sling Therapeutics @SlingTX]

With over 20 years of experience in #ThyroidEyeDisease (TED), our Chief Scientific Officer, Raymond Douglas, M.D., Ph.D., plays a key role in advancing our #TED pipeline. Thanks for sharing @CheckRare!

[CheckRare @CheckRare]

Raymond Douglas, MD, PhD, provides an overview of TED, including diagnosis challenges and current and emerging treatments for this rare disease #checkrare #thyroideyedisease
https://t.co/kfsimlVttH

[Sling Therapeutics @SlingTX]

We are working to develop an accessible therapy for thyroid eye disease (#TED) that offers the potential to significantly reduce the treatment burden for people with the condition.

Learn more: https://t.co/QwU6qpfUmU

[Sling Therapeutics @SlingTX]

In this video, our Chief Scientific Officer, Raymond Douglas, M.D., Ph.D., discusses who is at risk for #ThyroidEyeDisease (TED). https://t.co/cI5f3VdIr1

[Sling Therapeutics @SlingTX]

April is Women's Eye Health and Safety Month, an initiative of @PBA_savingsight that aims to educate women about #eyehealth and the steps they can take to help preserve their vision for the future. Learn more: https://t.co/ZcQMmQzKnk #WomensEyeHealthMonth

[Sling Therapeutics @SlingTX]

Our oral small molecule is being investigated in a Phase 2b/3 trial for thyroid eye disease (#TED). Learn more about our clinical progress: https://t.co/4ARw0ACsLt

[Sling Therapeutics @SlingTX]

For information about our LIDS clinical trial, actively recruiting eligible participants with moderate-to-severe #TED and a diagnosis of Graves’ disease and/or Hashimoto’s disease, visit https://t.co/a1wmZnMW7R.

[Sling Therapeutics @SlingTX]

Our Chief Scientific Officer, Raymond Douglas, M.D., Ph.D., shares a message about our ongoing mission to drive impactful, high-quality treatment options for people living with #TED. Learn more: https://t.co/4ARw0ACsLt

[Sling Therapeutics @SlingTX]

Our team of highly experienced executives, drug developers, and scientific advisors is focused on delivering potential new therapies for #ThyroidEyeDisease. Learn more: https://t.co/4ARw0ACsLt

[Sling Therapeutics @SlingTX]

We are evaluating the effectiveness of our investigational oral therapy for #ThyroidEyeDisease in a Phase 2b/3 clinical trial.

Learn more: https://t.co/a1wmZnMW7R

[Sling Therapeutics @SlingTX]

Our late-stage development program, now enrolling participants at sites across the U.S. and Canada, is evaluating an investigational therapy for people living with #ThyroidEyeDisease. Learn more: https://t.co/a1wmZnMW7R

[Sling Therapeutics @SlingTX]

TED is a #rare condition that affects about 20,000 people in the U.S. per year. This #RareDiseaseDay, we are proud to join advocates to raise awareness of the 300 million people worldwide living with a #raredisease.

Learn more: https://t.co/9bg5mbmJwl @rarediseaseday

[Sling Therapeutics @SlingTX]

We are actively recruiting people with moderate-to-severe thyroid eye disease (#TED) and a diagnosis of Graves’ disease and/or Hashimoto’s disease in our Phase 2b/3 clinical trial. Learn more: https://t.co/a1wmZnMW7R

[Sling Therapeutics @SlingTX]

The American Thyroid Association (@thyroidfriends) is dedicated to improving thyroid disease prevention, diagnosis, and treatment by educating the public about thyroid health. Learn more: https://t.co/MSDs3hgcUD.

[Sling Therapeutics @SlingTX]

If left untreated, thyroid eye disease (#TED) may potentially lead to severe vision problems or even #visionloss. Knowing the symptoms of TED may help to prevent irreversible damage to the eye.

Learn more via @TheEndoSociety: https://t.co/0t6iHUIuxz #LowVisionAwarenessMonth

[Sling Therapeutics @SlingTX]

Our oral therapy, currently in a Phase 2b/3 #clinical trial, offers the potential to ease the treatment burden for those living with thyroid eye disease (#TED).

Learn more: https://t.co/4ARw0ACsLt

[Sling Therapeutics @SlingTX]

Thyroid eye disease (#TED) may cause a range of progressive symptoms that can impact a person’s life in many adverse ways. That’s why our team is working with care to drive therapeutic solutions for people living with the condition. Learn more https://t.co/a1wmZnMW7R